Literature DB >> 27206711

Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran.

Sahar Fallahi-Shahabad1, Mohsen Mazidi2,3, Alireza Tavasoli1, Peyman Rezaie1, Fatemeh Rohani1, Simindokht Habibzadeh1, Emadodin Darchini-Maragheh1, Zohreh Sadat Sang Sefidi1, Mohammad Safarian1, Majid Ghayour Mobarhan1,4, Mohammad Taghi Rajabi1, Abdolreza Norouzy1, Seyed Mohammad Reza Parizadeh1, Saeid Akhlaghi1, Shima Tavalaie1, Fatemeh Firouzi1, Mohsen Nematy5.   

Abstract

BACKGROUND AND AIM: Obesity is one of the greatest public health concerns worldwide. Weight loss surgeries have been increased in recent decades due to the world's epidemic of obesity. The aim of this prospective study is investigating metabolic factors of morbid obese patients following Roux-en-Y gastric bypass surgery.
METHODS: This was a nonrandomized prospective cohort study conducted from 2010 to 2013 on 60 consecutive patients who had body mass index (BMI) of more than 40 kg/m(2) and met the surgical indication criteria of bariatric surgery. Upon discharge, patients were followed in outpatient clinic of Qaem Hospital, Mashhad, Iran, each 3 months for 12 months. Measurement of anthropometric and metabolic indices was done in each postoperative visit.
RESULTS: Mean BMI reduction was 15.26 ± 3.45 kg/m(2) in the patients with an average value of 28.84 ± 3.94 (range from 22 to 40 kg/m(2)), which was significantly lower than the base value (p < 0.001). After a 12-month follow up, patients had lower low-density lipoprotein, triglycerides, and total cholesterol (p < 0.001 for all the variables), while achieving a greater high-density lipoprotein (p = 0.004). An improvement was seen in all of hypertensive patients after a 3-month follow up and blood pressure remained within normal limit in further follow ups. Complete remission was observed in all the patients with obstructive sleep apnea.
CONCLUSION: It appears reasonable that multidisciplinary treatment including surgical alternatives should be concerned for all morbidly obese patients, considering high rate of failure of conservative medical therapy in this setting.

Entities:  

Keywords:  Metabolic improvement; Obese patients; Roux-en-Y gastric bypass surgery

Mesh:

Substances:

Year:  2016        PMID: 27206711     DOI: 10.1007/s12664-016-0661-0

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  41 in total

1.  Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.

Authors:  Ninh T Nguyen; Esteban Varela; Allen Sabio; Cam-Ly Tran; Michael Stamos; Samuel E Wilson
Journal:  J Am Coll Surg       Date:  2006-05-30       Impact factor: 6.113

2.  Open and laparoscopic Roux-en-Y gastric bypass: our techniques.

Authors:  Sayeed Ikramuddin; Michael L Kendrick; Todd A Kellogg; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

3.  Histological findings in the liver before and after gastric bypass.

Authors:  Attila Csendes; Gladys Smok; Ana Maria Burgos
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

4.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 5.  Bariatric surgery for type 2 diabetes.

Authors:  John B Dixon; Carel W le Roux; Francesco Rubino; Paul Zimmet
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

6.  Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors.

Authors:  C Lubrano; S Mariani; M Badiali; M Cuzzolaro; G Barbaro; S Migliaccio; G Genovesi; F Rossi; M Celanetti; D Fiore; M M Pandolfo; P Specchia; G Spera
Journal:  Int J Obes (Lond)       Date:  2010-04-20       Impact factor: 5.095

7.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

8.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

9.  Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes.

Authors:  Alexander D Miras; Ling Ling Chuah; Gerassimos Lascaratos; Sana Faruq; Ajay A Mohite; Priya R Shah; Mahi Gill; Sabrina N Jackson; Desmond G Johnston; Torsten Olbers; Carel W le Roux
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more
  3 in total

1.  Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients.

Authors:  Mohsen Mazidi; Hong-Kai Gao; Han Hui; Liang Li; Gordon A Ferns
Journal:  Indian J Gastroenterol       Date:  2017-08-05

Review 2.  Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.

Authors:  Mohsen Mazidi; Pedro Paulo P de Caravatto; John R Speakman; Ricardo V Cohen
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

3.  Effect of bariatric surgery on adiposity and metabolic profiles: A prospective cohort study in Middle-Eastern patients.

Authors:  Mohsen Mazidi; Peyman Rezaie; Ali Jangjoo; Alireza Tavassoli; Mohammad Taghi Rajabi; Andre Pascal Kengne; Mohsen Nematy
Journal:  World J Diabetes       Date:  2017-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.